ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages UroGen Pharma Ltd. Investors to Secure Counsel Before Important Deadline in Se

  • NEW YORK, NY / ACCESS Newswire / June 7, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of UroGen Pharma Ltd. (NASDAQ:URGN) between July 27, 2023 and May 15, 2025, both dates inclusive (the "Class Period").